Use of leptin for infant with low birth weight for prevention of obesity
CA 2459015 A1 · Owner: Cawthorne, Michael Anthony · Inventors: Stocker, Claire Joanne; Cawthorne, Michael Anthony
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention discloses the therapeutic and prophylactic administration of leptin to (i) an infant of low birth weight for age; (ii) a nursing mother of an infant, the infant having low birth weight for age; or (iii) a pregnant female predisposed to giving birth to an infant of low birth weight for age; for the prevention or treatment, in later life of the infant of a metabolic , disorder or other condition associated with low birth weight such as type 2 , diabetes, obesity, cardiovascular disease gestational diabetes, impaired , glucose tolerance insulin resistance, hypertension or syndrome X. It is thought that the beneficial properties of leptin may be due at least in part to an …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 28, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 28, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 28, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.